Cepheid CPHD today announced the release of Xpert Flu as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
The test, which runs on Cepheid's GeneXpert System, simultaneously detects and differentiates Flu A, Flu B, and 2009 H1N1 influenza virus in about one hour.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
